The J-Valve System is associated with positive 10-year outcomes for patients with severe AR, according to new research out of China. It also performs well in patients with severe AS.
SCAI has shared a new call to action as an observance of American Heart Month. The group is asking Congress to pass new pieces of legislation that could improve care for PAD patients and get important medical devices in the hands of interventional cardiologists.
The Magnolia, Texas, firm has seen rapid growth in recent years, being named to the Deloitte Technology Fast 500 in 2024 after logging revenue growth of 212% over a three-year period.
Sens. Tim Kaine, D-Va., and John Boozman, R-Ark., have introduced legislation to lift "arbitrary" caps on compensation for therapeutic and diagnostic medical physicists working in the VA.
Siemens self-reported a problem with software being inadvertently delivered to U.S. systems when the applications have not yet been cleared for use by the FDA.
The supply of Mo-99 and Tc-99m—the most commonly utilized medical isotopes in the world—could be cut by as much as 40% until the reactor in the Netherlands is up and running again.
Shockwave Medical, now a part of Johnson & Johnson MedTech, continues to gain momentum among U.S. cardiologists. According to one MedAxiom executive, IVL "brings an important dimension to cardiovascular care for patients with calcified coronary and peripheral arterial disease."
Imaging plays an essential role in addressing hepatic steatosis. Yet, radiologists have had almost zero involvement in shaping medical knowledge about the disease.
ACR, the Society of Interventional Radiology and others recently submitted a letter to 5 of the 7 contractors, expressing concern about trigger-point injections.
The J-Valve System is associated with positive 10-year outcomes for patients with severe AR, according to new research out of China. It also performs well in patients with severe AS.
